FDA NDC Directory · JSON-LD · Markdown

Saxenda

NDC 0169-2800 · HUMAN PRESCRIPTION DRUG · INJECTION, SOLUTION

Generic nameliraglutide
Labeler / ManufacturerNovo Nordisk
Marketing categoryNew Drug Application (innovator) · App NDA206321
Dosage form / routeINJECTION, SOLUTION · SUBCUTANEOUS
Active ingredientsLIRAGLUTIDE (6 mg/mL)
Marketing started20141231
Package count3

External sources

Source: openFDA. Public-domain (CC0).